Procedure Overview/Details |  | This test detects and determines the possible spread of neuroendocrine tumors (pheochromocytoma, carcinoids, paragangliomas, neuroblastomas, and medullary thyroid cancer). This test can also be used to assess nerve supply changes in the heart (cardiac sympathetic denervation).
This test involves pretreatment with a thyroid blocking agent to prevent the MIBG from going to your thyroid gland. You will be given an injection of a radioactive tracer (MIBG). Pictures of the tracer distribution will be taken 24, 48, and 72 hours after the injection.
Preparation
|